REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Clinical trials for REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on tough blood cancers: chemo plus transplant shows promise
Disease control Recruiting nowThis study tests a new approach for adults with aggressive blood cancers (like AML) that are likely to return after standard treatment. Participants receive a combination of chemotherapy drugs (decitabine plus FLAG-Ida) and low-dose radiation, followed immediately by a stem cell …
Matched conditions: REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo attack on stubborn leukemia: chemo then transplant
Disease control Recruiting nowThis early-phase trial tests a two-step approach for people with acute myeloid leukemia or related blood cancers that have returned or not responded to treatment. First, patients receive intensive chemotherapy (CLAG-M or FLAG-Ida) followed immediately by a reduced-intensity stem …
Matched conditions: REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC